Search by Drug Name or NDC

    NDC 70518-3209-01 RABEPRAZOLE SODIUM 20 mg/1 Details

    RABEPRAZOLE SODIUM 20 mg/1

    RABEPRAZOLE SODIUM is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is RABEPRAZOLE SODIUM.

    Product Information

    NDC 70518-3209
    Product ID 70518-3209_065d250e-56e7-4be0-e063-6294a90a930f
    Associated GPIs 49270076100620
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name RABEPRAZOLE SODIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name rabeprazole sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name RABEPRAZOLE SODIUM
    Labeler Name REMEDYREPACK INC.
    Pharmaceutical Class Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204237
    Listing Certified Through 2024-12-31

    Package

    NDC 70518-3209-01 (70518320901)

    NDC Package Code 70518-3209-1
    Billing NDC 70518320901
    Package 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-3209-1)
    Marketing Start Date 2021-09-21
    NDC Exclude Flag N
    Pricing Information N/A